News Articles and Montana BioScience Alliance Newsletters

MONTANA BIOSCIENCE ENTERPRISES IN THE NEWS

Microbion Corporation today announced that the company has published results from its topical pravibismane Phase 1b study in the peer-reviewed International Wound Journal.

A message from Scott Whittenburg, UM Vice President for Research and Creative Scholarship: “I’m happy to report that the research enterprise at UM continues to grow.”

Montana State University will send 17 students to one of the country’s premier celebrations of undergraduate research next week, where they will have the opportunity to present the research they have done in departments across the university. The National Conference on Undergraduate Research, or NCUR, will be held April 8-10 in Long Beach, California, and will feature undergraduate researchers from institutions nationwide.

The Montana BioScience Alliance and industry partners are proud to announce the successful 2024 Immersion Day at Rocky Vista University and both local hospitals, the Billings Clinic and Intermountain Health, on February 23, 2024. The Immersion Day follows the Careers in Healthcare Student Summit, hosted at Montana State University Billings, on October 27, 2023.

At first glance, a room in the basement of McGill Hall on the University of Montana campus appears like a private gym with treadmills, dumbbells and exercise bikes.  It seems like a good place for a workout. But the space is actually a research laboratory for students and faculty in UM’s School of Integrative Physiology and Athletic Training within the College of Health. 

ARTICLES OF INTEREST

National Cancer Institute, SBIR Development Center
|
August 30, 2023

Are you working to develop an innovative cancer technology? Take a step forward in your commercialization journey through the newly released FY2024 SBIR Contract Solicitation! This funding opportunity aims to provide early-stage funding to small businesses that are developing cancer technologies in areas defined by the National Cancer Institute.

U.S. Food and Drug Administration
|
July 16, 2023

The U.S. Food and Drug Administration converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval following a determination that a confirmatory trial verified clinical benefit.

National Institutes of Health
|
July 15, 2023

The PHS 2023-2 omnibus solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications have been released. The first application due date is Tuesday, September 5, 2023.

Centers for Disease Control and Prevention
|
June 22, 2023

The panel’s decision moves the U.S. one step closer to making jabs against respiratory syncytial virus available to the public this fall, when the disease typically begins to spread at higher levels.

The biennial report provides a national snapshot of the most pressing current and anticipated talent needs of the nation’s dynamic life science industry. This year’s report distills a set of key themes sourced from 185 executive interviews and nearly 700 survey responses from companies in eighteen states and Puerto Rico, as well as an assessment of nearly 2.8M job postings from life science companies over the last four years.

NEWSLETTER

Newsletter
|
February 20, 2024

View the Winter II 2024 Newsletter now!

Newsletter
|
December 21, 2023

View the Winter 2023 Newsletter now!